ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

Preptin; Proinsulin-Like Growth Factor-II

Specificity

This assay has high sensitivity and excellent specificity for detection of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE).
No significant cross-reactivity or interference between Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and the recovery rates were calculated by comparing the measured value to the expected amount of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-97 91
EDTA plasma(n=5) 87-96 91
heparin plasma(n=5) 91-102 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-101% 97-104% 86-96% 83-104%
EDTA plasma(n=5) 94-102% 99-105% 78-99% 80-95%
heparin plasma(n=5) 80-104% 87-102% 78-90% 78-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Appl Physiol Nutr Metab Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults PubMed: 25675353
Journal of Pediatric Endocrinology and Metabolism Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection PubMed: 25719300
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
CEA707Hu ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA707Hu Multiplex Assay Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.